Clinical Trial Update: Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating bendamustine, lenalidomide, and low-dose dexamethasone for relapsed multiple myeloma; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Decadron (Dexamethasone)
• Revlimid (lenalidomide)
• Treanda (Bendamustine)

Snippet

Sponsor: Gruppo Italiano Studio Linfomi | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN